Embark Veterinary, Inc. Selects Colossus Creative Co. as Agency of Record

Embark Veterinary, a global leader in dog health and genetics, today announced the appointment of independent creative company Colossus Creative Co. as its agency of record. The collaboration is focused on a transformative brand campaign set to launch in March 2024 spotlighting Embark's unique position in the more than $345 million canine genetics and health industry.

The upcoming brand campaign with Colossus Creative Co. is poised to unveil a fresh and exciting narrative, highlighting Embark's dedication to canine well-being, cutting-edge genetic research, and its role as an industry leader. The campaign is set to launch in March 2024 across various media channels, providing a captivating and immersive experience for audiences.

“Colossus’ creativity, strategic approach, and commitment to excellence align perfectly with our brand values,” said JR Blaszek, CMO at Embark. "We believe this collaboration will not only elevate our brand but also create a lasting impact in the industry."

Founded in 2015, Embark is the sole canine genetics testing company utilising research-grade genotyping technology. Its dog DNA tests are built on the leading research platform for dog genetics, analysing 230,000 genetic markers - more than twice of any competitor. This differentiator underscores Embark's commitment to providing the most accurate and comprehensive insights into canine health.

Embark’s team of dog-loving scientists and veterinarians share a mission of utilising research and data to advance canine health. Today, Embark's discoveries are propelled by insights from over 2 million dogs in its extensive database, contributing to its mission of transforming the way humans care for dogs.